Yokoi H - Search Results

1

One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).

Ohki T, Angle JF, Yokoi H, Jaff MR, Popma J, Piegari G, Kanaoka Y; OSPREY investigators. Ohki T, et al. Among authors: yokoi h. J Vasc Surg. 2016 Feb;63(2):370-6.e1. doi: 10.1016/j.jvs.2015.08.093. Epub 2015 Oct 17. J Vasc Surg. 2016. PMID: 26483003 Free article. Clinical Trial.

2

The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.

Uchida T, Popma J, Stone GW, Ellis SG, Turco MA, Ormiston JA, Muramatsu T, Nakamura M, Nanto S, Yokoi H, Baim DS. Uchida T, et al. Among authors: yokoi h. JACC Cardiovasc Interv. 2010 Apr;3(4):403-11. doi: 10.1016/j.jcin.2010.01.010. JACC Cardiovasc Interv. 2010. PMID: 20398868 Free article.

3

Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry.

Suzuki K, Iida O, Soga Y, Hirano K, Inoue N, Uematsu M, Yokoi H, Muramatsu T, Nanto S, Nobuyoshi M, Meguro T. Suzuki K, et al. Among authors: yokoi h. Circ J. 2011;75(4):939-44. doi: 10.1253/circj.cj-10-1029. Epub 2011 Feb 11. Circ J. 2011. PMID: 21325721 Free article. Clinical Trial.

4

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery.

Soga Y, Iida O, Hirano K, Suzuki K, Tosaka A, Yokoi H, Nobuyoshi M. Soga Y, et al. Among authors: yokoi h. J Vasc Surg. 2011 Oct;54(4):1058-66. doi: 10.1016/j.jvs.2011.03.286. Epub 2011 Aug 31. J Vasc Surg. 2011. PMID: 21880459 Free article.

5

Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.

Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS; Zilver PTX Investigators. Dake MD, et al. Circ Cardiovasc Interv. 2011 Oct 1;4(5):495-504. doi: 10.1161/CIRCINTERVENTIONS.111.962324. Epub 2011 Sep 27. Circ Cardiovasc Interv. 2011. PMID: 21953370 Clinical Trial.

6

Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.

Ohki T, Yokoi H, Kichikawa K, Kimura T, Snyder SA, Ragheb AO, O'Leary EE, Jaff MR, Ansel GM, Dake MD. Ohki T, et al. Among authors: yokoi h. J Endovasc Ther. 2014 Oct;21(5):644-53. doi: 10.1583/14-4753.1. J Endovasc Ther. 2014. PMID: 25290792 Clinical Trial.

7

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).

Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW. Patel MR, et al. Among authors: yokoi h. J Am Coll Cardiol. 2015 Mar 10;65(9):931-41. doi: 10.1016/j.jacc.2014.12.036. J Am Coll Cardiol. 2015. PMID: 25744011 Free PMC article.

8

1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis.

Iida O, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M; ZEPHYR Investigators. Iida O, et al. Among authors: yokoi h. JACC Cardiovasc Interv. 2015 Jul;8(8):1105-1112. doi: 10.1016/j.jcin.2015.03.022. Epub 2015 Jun 24. JACC Cardiovasc Interv. 2015. PMID: 26117463 Free article.

9

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 12-Month Results.

Yokoi H, Ohki T, Kichikawa K, Nakamura M, Komori K, Nanto S, O'Leary EE, Lottes AE, Snyder SA, Dake MD. Yokoi H, et al. JACC Cardiovasc Interv. 2016 Feb 8;9(3):271-277. doi: 10.1016/j.jcin.2015.09.035. JACC Cardiovasc Interv. 2016. PMID: 26847118 Free article. Clinical Trial.

10

The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These Lesions.

Iida O, Takahara M, Soga Y, Hirano K, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M; ZEPHYR Investigators. Iida O, et al. Among authors: yokoi h. JACC Cardiovasc Interv. 2016 Apr 25;9(8):828-834. doi: 10.1016/j.jcin.2016.01.007. JACC Cardiovasc Interv. 2016. PMID: 27101908 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

941 results

Search Page